191 related articles for article (PubMed ID: 31291697)
1. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
Pakdel M; Karin Hedström A; Bidkhori M; Hadei M; Kazemi Moghaddam V; Sarmadi M; Zohdi S; Marufi N
Acta Neurol Scand; 2019 Nov; 140(5):328-335. PubMed ID: 31291697
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data.
Moghaddam VK; Dickerson AS; Bazrafshan E; Seyedhasani SN; Najafi F; Hadei M; Momeni J; Moradi G; Sarmadi M
BMC Neurol; 2021 Apr; 21(1):145. PubMed ID: 33794796
[TBL] [Abstract][Full Text] [Related]
3. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
4. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Ashtari F; Baghbanian SM; Razazian N; Moghadasi AN; Bayati A; Azimi AR; Beladimoghadam N; Harirchian MH; Poursadeghfard M; Navardi S; Shirkoohi R; Heidari H; Ghaffari M; Eskandarieh S
BMC Neurol; 2022 Mar; 22(1):76. PubMed ID: 35248009
[TBL] [Abstract][Full Text] [Related]
6. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
7. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
9. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
12. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
13. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.
Moghaddam VK; Sarmadi M; Tatari M; Najafi F; Esmaeili A; Hadei M
Mult Scler Relat Disord; 2018 Aug; 24():184-189. PubMed ID: 30077941
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic factors in childhood and the risk of multiple sclerosis.
Nielsen NM; Jørgensen KT; Bager P; Stenager E; Pedersen BV; Hjalgrim H; Koch-Henriksen N; Frisch M
Am J Epidemiol; 2013 Jun; 177(11):1289-95. PubMed ID: 23660795
[TBL] [Abstract][Full Text] [Related]
16. Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Public Health; 2019 Oct; 175():138-144. PubMed ID: 31476710
[TBL] [Abstract][Full Text] [Related]
17. 18-year temporal trend of multiple sclerosis in southern Iran.
Mobasheri F; Fararouei M; Hasanzadeh J; Jaberi AR
Mult Scler Relat Disord; 2021 Jul; 52():103018. PubMed ID: 34023774
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in multiple sclerosis epidemiology and treatment response.
Magyari M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931196
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
Molazadeh N; Mohebi F; Altafi D; Sahraian MA
Mult Scler Relat Disord; 2021 Jan; 47():102605. PubMed ID: 33217696
[TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction levels in iranian women suffering from multiple sclerosis.
Dehghan-Nayeri N; Khakbazan Z; Ghafoori F; Nabavi SM
Mult Scler Relat Disord; 2017 Feb; 12():49-53. PubMed ID: 28283107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
